129 related articles for article (PubMed ID: 19853363)
1. New insights into DNA-binding behavior of Wilms tumor protein (WT1)--a dual study.
Nurmemmedov E; Yengo RK; Uysal H; Karlsson R; Thunnissen MM
Biophys Chem; 2009 Dec; 145(2-3):116-25. PubMed ID: 19853363
[TBL] [Abstract][Full Text] [Related]
2. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
[TBL] [Abstract][Full Text] [Related]
3. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
[TBL] [Abstract][Full Text] [Related]
4. Kinetic behaviour of WT 1's zinc finger domain in binding to the alpha-actinin-1 mRNA.
Nurmemmedov E; Yengo RK; Ladomery MR; Thunnissen MM
Arch Biochem Biophys; 2010 May; 497(1-2):21-7. PubMed ID: 20193655
[TBL] [Abstract][Full Text] [Related]
5. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
6. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
7. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene.
Anant S; Axenovich SA; Madden SL; Rauscher FJ; Subramanian KN
Oncogene; 1994 Nov; 9(11):3113-26. PubMed ID: 7936634
[TBL] [Abstract][Full Text] [Related]
8. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.
Morrison AA; Venables JP; Dellaire G; Ladomery MR
Biochem Cell Biol; 2006 Oct; 84(5):789-98. PubMed ID: 17167543
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
[TBL] [Abstract][Full Text] [Related]
10. DNA-induced alpha-helix capping in conserved linker sequences is a determinant of binding affinity in Cys(2)-His(2) zinc fingers.
Laity JH; Dyson HJ; Wright PE
J Mol Biol; 2000 Jan; 295(4):719-27. PubMed ID: 10656784
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
Sakamoto Y; Yoshida M; Semba K; Hunter T
Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the DNA binding characteristics of the related zinc finger proteins WT1 and EGR1.
Hamilton TB; Borel F; Romaniuk PJ
Biochemistry; 1998 Feb; 37(7):2051-8. PubMed ID: 9485332
[TBL] [Abstract][Full Text] [Related]
13. Contribution of individual amino acids to the RNA binding activity of the Wilms' tumor suppressor protein WT1.
Weiss TC; Romaniuk PJ
Biochemistry; 2009 Jan; 48(1):148-55. PubMed ID: 19123921
[TBL] [Abstract][Full Text] [Related]
14. DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis.
Svensson E; Eriksson H; Gekas C; Olofsson T; Richter J; Gullberg U
Exp Cell Res; 2005 Aug; 308(1):211-21. PubMed ID: 15907324
[TBL] [Abstract][Full Text] [Related]
15. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
[TBL] [Abstract][Full Text] [Related]
16. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
Yang C; Romaniuk PJ
Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
[TBL] [Abstract][Full Text] [Related]
17. Expression, purification, and characterization of the 4 zinc finger region of human tumor suppressor WT1.
Nurmemmedov E; Thunnissen M
Protein Expr Purif; 2006 Apr; 46(2):379-89. PubMed ID: 16343939
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
[TBL] [Abstract][Full Text] [Related]
19. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ
Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.
Morris JF; Madden SL; Tournay OE; Cook DM; Sukhatme VP; Rauscher FJ
Oncogene; 1991 Dec; 6(12):2339-48. PubMed ID: 1662794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
